A medicine treats a life-threatening disease, has promising early clinical signals, but lacks complete Phase III data. There are existing treatments, but none demonstrate major improvement. Which is the MOST appropriate pathway?

Question

BlackTom AI · Accepted Answer

Accelerated approval fits because it allows earlier authorization for serious or life‑threatening conditions when there is promising but not yet definitive evidence.

1) Relevant knowledge points and concepts
- Accelerated (or accelerated/conditional) approval: permits marketing based on surrogate or intermediate clinical endpoints reasonably likely to predict clinical benefit for serious/life‑threatening diseases, with requirement for confirmatory Phase III/post‑marketing trials.  
- Standard pathway: requires complete, well‑controlled Phase III evidence of safety and efficacy before approval.  
- Priority pathway (expedited review): shortens review time for applications that appear to offer a major advance, but does not itself relax evidentiary standards.  
- Provisional pathway: terminology varies by jurisdiction, but typically grants temporary access under very limited conditions and is used when evidence is extremely limited or compassionate use is needed.

2) Step‑by‑step reasoning
- The disease is life‑threatening → favors use of expedited/conditional regulatory approaches.  
- Clinical signals are promising but Phase III data are incomplete → insufficient for standard approval that requires robust phase III evidence.  
- Existing treatments exist but none show major improvement → there is an unmet medical need and potential benefit from earlier access.

3) Intermediate logic/calculation steps
- Standard pathway? No — lacks completed Phase III data, so standard approval is not appropriate.  
- Priority pathway? No — priority review speeds assessment time but does not relax the requirement for substantial phase III evidence; it’s intended for therapies demonstrating major improvement. The stem says existing treatments do not demonstrate major improvement, so priority might not apply.  
- Provisional pathway? Unclear/conditional in many jurisdictions and typically used when evidence is extremely limited or under compassionate access; the scenario better matches a formal conditional/accelerated approval tied to confirmatory trials.  
- Accelerated pathway? Yes — fits all elements: serious disease, promising early signals, incomplete Phase III, existing therapies inadequate, and need for post‑approval confirmatory trials.

4) Why the correct answer is correct
Accelerated approval is specifically designed for life‑threatening conditions with preliminary evidence that suggests benefit but where full Phase III proof is pending; it enables earlier patient access while requiring confirmatory studies.

5) Why other options are incorrect (brief)
- Standard: requires full Phase III evidence — not met.  
- Provisional: terminology/vigilance differs and is less consistently used; the described regulatory mechanism that matches is accelerated approval.  
- Priority: speeds review but does not substitute for incomplete Phase III evidence or allow approval on surrogate/intermediate endpoints alone.

6) Conclusion
Therefore, the MOST appropriate pathway is c. Accelerated pathway, which matches the provided answer.

A medicine treats a life-threatening disease, has promising early clinical signals, but lacks complete Phase III data. There are existing treatments, but none demonstrate major improvement. Which is the MOST appropriate pathway?单项选择题

类似问题

You own a bond that pays $64 in interest annually. The face value is $1,000 and the current market price is $1,021.61. The bond matures in 11 years. What is the yield to maturity?

Which of the following statements is CORRECT?

It will cost $9,600 to acquire an ice cream cart that is expected to produce cash inflows of $3,600 a year for three years. After the three years, the cart is expected to be worthless. What is the payback period?

A 3.25 percent Treasury bond is quoted at a price of 99.04. The bond pays interest semiannually. What is the current yield?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单